Nordic Life Science days

Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic

Interview with Ella Radvogin, Clinical Psychologist at Alex Therapeutics

Untangling the dualistic components of the RAS in PF the Yin and Yang

Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients

Patient insights to shape development of a dCBT for IPF patients